Vamil Divan
Stock Analyst at Guggenheim
(3.09)
# 518
Out of 5,218 analysts
256
Total ratings
56.86%
Success rate
32.97%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Keros Therapeutics | Downgrades: Neutral | n/a | n/a | n/a | 4 | Dec 16, 2024 | |
Pfizer | Maintains: Buy | 35 33 | 25.59 | 28.96% | 14 | Dec 11, 2024 | |
Revance Therapeutics | Maintains: Neutral | 7 4 | 3.08 | 0.65% | 6 | Dec 10, 2024 | |
Absci | Reiterates: Buy | 10 10 | 3.7 | 170.27% | 2 | Dec 3, 2024 | |
Johnson & Johnson | Maintains: Neutral | 156 162 | 146.69 | 10.44% | 11 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 212 221 | 173.5 | 27.38% | 19 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 56 64 | 44 | 45.45% | 4 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 23 41 | 17.3 | 136.99% | 7 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 6 | 1.81 | 231.49% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 70 95 | 71.53 | 32.81% | 4 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 77 77 | 56.38 | 36.57% | 8 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 55 | n/a | n/a | 1 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 245 330 | n/a | n/a | 7 | Jan 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 19 20 | 5.34 | 274.53% | 9 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 21 18 | n/a | n/a | 2 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 26 | 0.36 | 7122.22% | 2 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 35 40 | n/a | n/a | 3 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 8 9 | 1.14 | 689.47% | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | n/a | n/a | n/a | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 13 2 | n/a | n/a | 5 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 27 19 | 17.3 | 9.83% | 7 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 95 98 | 126.68 | -22.64% | 8 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 36 34 | 30.46 | 11.62% | 7 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 20 10 | 2.8 | 257.14% | 3 | May 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 51 49 | 90.01 | -45.56% | 3 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 315 356 | 789.07 | -54.88% | 15 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 8 6 | 3.27 | 83.49% | 1 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 144 154 | 38.47 | 300.31% | 9 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 15 | 11.51 | 30.32% | 5 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 6 | Dec 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 7 4 | n/a | n/a | 6 | Nov 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 11 19 | n/a | n/a | 8 | Sep 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 35 | n/a | n/a | 13 | Aug 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | n/a | n/a | n/a | 13 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 36 30 | n/a | n/a | 4 | May 21, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 161 155 | n/a | n/a | 10 | Mar 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 71 81 | 102.09 | -20.66% | 7 | Oct 11, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 15 | 7.35 | 104.08% | 4 | Aug 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 58 61 | 55.73 | 9.46% | 5 | Jul 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 103 | 2.23 | 4518.83% | 3 | Jan 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 45 55 | n/a | n/a | 1 | Sep 19, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 66 120 | n/a | n/a | 4 | Dec 20, 2016 |